CD 12001
Alternative Names: CD-12001Latest Information Update: 28 Feb 2023
At a glance
- Originator Chipscreen Biosciences
- Class Antivirals
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Viral infections
Most Recent Events
- 04 Jan 2023 Preclinical trials in Viral infections in China (unspecified route) (Chipscreen Biosciences Pipeline, January 2023)